Malignant neoplasm of unspecified part of right adrenal gland
ICD-10 C74.91 is a billable code used to indicate a diagnosis of malignant neoplasm of unspecified part of right adrenal gland.
C74.91 refers to a malignant neoplasm located in the right adrenal gland, which is part of the endocrine system responsible for hormone production. The adrenal glands produce hormones such as cortisol, aldosterone, and adrenaline, which play crucial roles in metabolism, immune response, and stress management. Malignant neoplasms of the adrenal gland can lead to various endocrine disorders due to the overproduction or underproduction of these hormones. Symptoms may include hypertension, weight changes, and metabolic disturbances. Diagnosis typically involves imaging studies such as CT or MRI scans, followed by biopsy for histological confirmation. Treatment options may include surgical resection, radiation therapy, and chemotherapy, depending on the tumor's characteristics and stage. Accurate coding is essential for proper treatment planning and reimbursement, as well as for tracking outcomes in patients with adrenal malignancies.
Detailed clinical history, hormone levels, imaging studies, and pathology reports.
Patients presenting with symptoms of Cushing's syndrome, adrenal insufficiency, or hypertension.
Endocrinologists must document hormone levels and any metabolic effects to support the diagnosis.
Comprehensive tumor staging, treatment plans, and follow-up care documentation.
Patients undergoing treatment for adrenal tumors, including surgical and chemotherapeutic interventions.
Oncologists should ensure clear documentation of tumor type and response to treatment.
Used when a biopsy is performed to confirm malignancy in the adrenal gland.
Pathology report confirming malignancy and imaging studies.
Endocrinologists and oncologists should ensure clear documentation of the biopsy findings.
Specifying the right adrenal gland is crucial for accurate diagnosis and treatment planning, as different glands may produce different hormonal profiles and have varying implications for patient management.
